Risk Factors and Comparative Safety of Anti <scp>‐PD</scp> ‐1 Combination Therapies in Advanced Melanoma: A Nationwide Real‐World Cohort Study From China

Yuan Qiao, Xiao Fu, Sundus Shukar, Weihong Ge, Wei Yang, Ren bin Jiang, Xiaoyan Dai, Haisheng Chen, Jinyi Zhao, Meng Tang, Fei Mu, Hao Wang, Qiuhui Wu, Xing Xia, Yunan Zhang, Suzhi Ji, Ying Xu, Ruixin Cao, Jiexin Wang, Yu Yao, Jingwen Wang, Yu Fang

Open source

DOI: 10.1002/cam4.71694
Published: 2026-04
Container: Cancer Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.71694,
  title = {Risk Factors and Comparative Safety of Anti
                    <scp>‐PD</scp>
                    ‐1 Combination Therapies in Advanced Melanoma: A Nationwide Real‐World Cohort Study From China},
  author = {Yuan Qiao and Xiao Fu and Sundus Shukar and Weihong Ge and Wei Yang and Ren bin Jiang and Xiaoyan Dai and Haisheng Chen and Jinyi Zhao and Meng Tang and Fei Mu and Hao Wang and Qiuhui Wu and Xing Xia and Yunan Zhang and Suzhi Ji and Ying Xu and Ruixin Cao and Jiexin Wang and Yu Yao and Jingwen Wang and Yu Fang},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.71694},
  url = {https://doi.org/10.1002/cam4.71694}
}

RIS

TY  - JOUR
TI  - Risk Factors and Comparative Safety of Anti
                    <scp>‐PD</scp>
                    ‐1 Combination Therapies in Advanced Melanoma: A Nationwide Real‐World Cohort Study From China
AU  - Yuan Qiao
AU  - Xiao Fu
AU  - Sundus Shukar
AU  - Weihong Ge
AU  - Wei Yang
AU  - Ren bin Jiang
AU  - Xiaoyan Dai
AU  - Haisheng Chen
AU  - Jinyi Zhao
AU  - Meng Tang
AU  - Fei Mu
AU  - Hao Wang
AU  - Qiuhui Wu
AU  - Xing Xia
AU  - Yunan Zhang
AU  - Suzhi Ji
AU  - Ying Xu
AU  - Ruixin Cao
AU  - Jiexin Wang
AU  - Yu Yao
AU  - Jingwen Wang
AU  - Yu Fang
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.71694
UR  - https://doi.org/10.1002/cam4.71694
ER  -

APA

Qiao, Y., Fu, X., Shukar, S., Ge, W., Yang, W., Jiang, R. B., Dai, X., Chen, H., Zhao, J., Tang, M., Mu, F., Wang, H., Wu, Q., Xia, X., Zhang, Y., Ji, S., Xu, Y., Cao, R., Wang, J., Yao, Y., Wang, J., & Fang, Y. (2026). Risk Factors and Comparative Safety of Anti <scp>‐PD</scp> ‐1 Combination Therapies in Advanced Melanoma: A Nationwide Real‐World Cohort Study From China. Cancer Medicine. https://doi.org/10.1002/cam4.71694

Source records

crossref · retrieved 2026-09-27T10:56:35.638Z